140 related articles for article (PubMed ID: 20527970)
1. 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.
Micheli F; Cavanni P; Andreotti D; Arban R; Benedetti R; Bertani B; Bettati M; Bettelini L; Bonanomi G; Braggio S; Carletti R; Checchia A; Corsi M; Fazzolari E; Fontana S; Marchioro C; Merlo-Pich E; Negri M; Oliosi B; Ratti E; Read KD; Roscic M; Sartori I; Spada S; Tedesco G; Tarsi L; Terreni S; Visentini F; Zocchi A; Zonzini L; Di Fabio R
J Med Chem; 2010 Jul; 53(13):4989-5001. PubMed ID: 20527970
[TBL] [Abstract][Full Text] [Related]
2. 1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.
Micheli F; Cavanni P; Arban R; Benedetti R; Bertani B; Bettati M; Bettelini L; Bonanomi G; Braggio S; Checchia A; Davalli S; Di Fabio R; Fazzolari E; Fontana S; Marchioro C; Minick D; Negri M; Oliosi B; Read KD; Sartori I; Tedesco G; Tarsi L; Terreni S; Visentini F; Zocchi A; Zonzini L
J Med Chem; 2010 Mar; 53(6):2534-51. PubMed ID: 20170186
[TBL] [Abstract][Full Text] [Related]
3. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
4. 2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.
Carter DS; Cai HY; Lee EK; Iyer PS; Lucas MC; Roetz R; Schoenfeld RC; Weikert RJ
Bioorg Med Chem Lett; 2010 Jul; 20(13):3941-5. PubMed ID: 20570146
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.
Shao L; Wang F; Malcolm SC; Ma J; Hewitt MC; Campbell UC; Bush LR; Spicer NA; Engel SR; Saraswat LD; Hardy LW; Koch P; Schreiber R; Spear KL; Varney MA
Bioorg Med Chem; 2011 Jan; 19(1):663-76. PubMed ID: 21093273
[TBL] [Abstract][Full Text] [Related]
6. 1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: further insights into a class of triple re-uptake inhibitors.
Micheli F; Cavanni P; Bettati M; Bonanomi G; Di Fabio R; Fazzolari E; Marchioro C; Roscic M; Tarsi L; Visentini F; Zonzini L; Worby A
Bioorg Med Chem; 2011 Jun; 19(11):3451-61. PubMed ID: 21550808
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis and antidepressant activities of aryl alkanol piperidine derivatives].
Zheng YY; Gao K; Weng ZJ; Li JQ
Yao Xue Xue Bao; 2010 Mar; 45(3):324-9. PubMed ID: 21351508
[TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor.
Aluisio L; Lord B; Barbier AJ; Fraser IC; Wilson SJ; Boggs J; Dvorak LK; Letavic MA; Maryanoff BE; Carruthers NI; Bonaventure P; Lovenberg TW
Eur J Pharmacol; 2008 Jun; 587(1-3):141-6. PubMed ID: 18499098
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.
Lee KH; Park CE; Min KH; Shin YJ; Chung CM; Kim HH; Yoon HJ; Won-Kim ; Ryu EJ; Shin YJ; Nam HS; Cho JW; Lee HY
Bioorg Med Chem Lett; 2010 Sep; 20(18):5567-71. PubMed ID: 20724153
[TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
[TBL] [Abstract][Full Text] [Related]
12. 1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.
Vu AT; Cohn ST; Zhang P; Kim CY; Mahaney PE; Bray JA; Johnston GH; Koury EJ; Cosmi SA; Deecher DC; Smith VA; Harrison JE; Leventhal L; Whiteside GT; Kennedy JD; Trybulski EJ
J Med Chem; 2010 Mar; 53(5):2051-62. PubMed ID: 20131864
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).
O'Neill DJ; Adedoyin A; Alfinito PD; Bray JA; Cosmi S; Deecher DC; Fensome A; Harrison J; Leventhal L; Mann C; McComas CC; Sullivan NR; Spangler TB; Uveges AJ; Trybulski EJ; Whiteside GT; Zhang P
J Med Chem; 2010 Jun; 53(11):4511-21. PubMed ID: 20462211
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.
Carlier PR; Lo MM; Lo PC; Richelson E; Tatsumi M; Reynolds IJ; Sharma TA
Bioorg Med Chem Lett; 1998 Mar; 8(5):487-92. PubMed ID: 9871604
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo characterization of PA01, a novel promising triple reuptake inhibitor.
Hou J; Xing Y; Zuo D; Wu Y; Tian J; Meng Q; Yang M
Physiol Behav; 2015 Jan; 138():141-9. PubMed ID: 25447484
[TBL] [Abstract][Full Text] [Related]
16. Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.
Shao L; Hewitt MC; Wang F; Malcolm SC; Ma J; Campbell JE; Campbell UC; Engel SR; Spicer NA; Hardy LW; Schreiber R; Spear KL; Varney MA
Bioorg Med Chem Lett; 2011 Mar; 21(5):1438-41. PubMed ID: 21310609
[TBL] [Abstract][Full Text] [Related]
17. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
[TBL] [Abstract][Full Text] [Related]
18. 1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.
Zhang P; Terefenko EA; Bray J; Deecher D; Fensome A; Harrison J; Kim C; Koury E; Mark L; McComas CC; Mugford CA; Trybulski EJ; Vu AT; Whiteside GT; Mahaney PE
J Med Chem; 2009 Sep; 52(18):5703-11. PubMed ID: 19722525
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists.
Micheli F; Arista L; Bertani B; Braggio S; Capelli AM; Cremonesi S; Di-Fabio R; Gelardi G; Gentile G; Marchioro C; Pasquarello A; Provera S; Tedesco G; Tarsi L; Terreni S; Worby A; Heidbreder C
J Med Chem; 2010 Oct; 53(19):7129-39. PubMed ID: 20839775
[TBL] [Abstract][Full Text] [Related]
20. Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.
Gray DL; Xu W; Campbell BM; Dounay AB; Barta N; Boroski S; Denny L; Evans L; Stratman N; Probert A
Bioorg Med Chem Lett; 2009 Dec; 19(23):6604-7. PubMed ID: 19854053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
